US regulators have approved the first at-home vaginal self-collection device for cervical cancer screening, offering women an alternative to in-clinic exams. The Teal Wand, developed by women’s...
An international group of ovarian cancer research charities has launched a new AI-focused grant aimed at accelerating progress in one of the most underfunded and least...
Paxman’s recent public offer to acquire its competitor Dignitana has been accepted, signifying a historical milestone for the two companies and heralding the start of a brand-new...
A new daily pill for endometriosis has been approved for use on the NHS and could help over a thousand women in England every year manage...
Women with endometriosis face significantly higher risk of early menopause Women with endometriosis are seven times more likely to undergo surgical menopause and face increased risks...
Diagnostics company Visby Medical has been granted De Novo authorisation for the Visby Medical Women’s Sexual Health Test by the U.S. Food and Drug Administration (FDA)...
Covera Health has announced the launch of Protect Her – an AI-powered solution designed to enhance early detection of critical health conditions predominantly impacting women ages...
Mammograms used in combination with AI may reveal much more than cancer, but can also be used to assess the amount of calcium build up in...
Screenings for breast cancer in the UK have caught more than 60,000 cases, however, participation in cancer screening is struggling to return to pre-Covid levels. In...
Standard NHS procedures for processing gestational diabetes blood sugar tests lead to more than 50 per cent of cases being missed, shows research, which could lead...
